Efficacy and safety of osilodrostat in patients with Cushing's disease (LINC 3): a multicentre phase III study with a double-blind, randomised withdrawal phase

Rosario Pivonello, Maria Fleseriu, John Newell‐Price, Xavier Bertagna, James W. Findling, Akira Shimatsu, Feng Gu, Richard J. Auchus, Rattana Leelawattana, Eun Jig Lee,

The Lancet Diabetes & Endocrinology · 2020 · 211 citations · 19 references

Concepts

References

19